208 related articles for article (PubMed ID: 32845957)
21. Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia.
Sun L; Crotty ML; Sensel M; Sather H; Navara C; Nachman J; Steinherz PG; Gaynon PS; Seibel N; Mao C; Vassilev A; Reaman GH; Uckun FM
Clin Cancer Res; 1999 Aug; 5(8):2112-20. PubMed ID: 10473095
[TBL] [Abstract][Full Text] [Related]
22. Analysis of Ikaros family splicing variants in human hematopoietic lineages.
Matulić M; Paradzik M; Puskarić BJ; Stipić J; Antica M
Coll Antropol; 2010 Mar; 34(1):59-62. PubMed ID: 20432734
[TBL] [Abstract][Full Text] [Related]
23. Loss of B Cells in Patients with Heterozygous Mutations in IKAROS.
Kuehn HS; Boisson B; Cunningham-Rundles C; Reichenbach J; Stray-Pedersen A; Gelfand EW; Maffucci P; Pierce KR; Abbott JK; Voelkerding KV; South ST; Augustine NH; Bush JS; Dolen WK; Wray BB; Itan Y; Cobat A; Sorte HS; Ganesan S; Prader S; Martins TB; Lawrence MG; Orange JS; Calvo KR; Niemela JE; Casanova JL; Fleisher TA; Hill HR; Kumánovics A; Conley ME; Rosenzweig SD
N Engl J Med; 2016 Mar; 374(11):1032-1043. PubMed ID: 26981933
[TBL] [Abstract][Full Text] [Related]
24. Direct interaction of Ikaros and Foxp1 modulates expression of the G protein-coupled receptor G2A in B-lymphocytes and acute lymphoblastic leukemia.
Bond J; Domaschenz R; Roman-Trufero M; Sabbattini P; Ferreiros-Vidal I; Gerrard G; Asnafi V; Macintyre E; Merkenschlager M; Dillon N
Oncotarget; 2016 Oct; 7(40):65923-65936. PubMed ID: 27588474
[TBL] [Abstract][Full Text] [Related]
25. Abnormal hematopoiesis and autoimmunity in human subjects with germline IKZF1 mutations.
Hoshino A; Okada S; Yoshida K; Nishida N; Okuno Y; Ueno H; Yamashita M; Okano T; Tsumura M; Nishimura S; Sakata S; Kobayashi M; Nakamura H; Kamizono J; Mitsui-Sekinaka K; Ichimura T; Ohga S; Nakazawa Y; Takagi M; Imai K; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ogawa S; Kojima S; Nonoyama S; Morio T; Kanegane H
J Allergy Clin Immunol; 2017 Jul; 140(1):223-231. PubMed ID: 27939403
[TBL] [Abstract][Full Text] [Related]
26. Inborn errors of IKAROS and AIOLOS.
Yamashita M; Morio T
Curr Opin Immunol; 2021 Oct; 72():239-248. PubMed ID: 34265590
[TBL] [Abstract][Full Text] [Related]
27. Harnessing of the nucleosome-remodeling-deacetylase complex controls lymphocyte development and prevents leukemogenesis.
Zhang J; Jackson AF; Naito T; Dose M; Seavitt J; Liu F; Heller EJ; Kashiwagi M; Yoshida T; Gounari F; Petrie HT; Georgopoulos K
Nat Immunol; 2011 Nov; 13(1):86-94. PubMed ID: 22080921
[TBL] [Abstract][Full Text] [Related]
28. AIOLOS-Associated Inborn Errors of Immunity.
Yamashita M; Morio T
J Clin Immunol; 2024 May; 44(6):128. PubMed ID: 38773004
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia.
Ge Z; Guo X; Li J; Hartman M; Kawasawa YI; Dovat S; Song C
Oncotarget; 2015 Dec; 6(39):42300-11. PubMed ID: 26517351
[TBL] [Abstract][Full Text] [Related]
30. Protein signaling and regulation of gene transcription in leukemia: role of the Casein Kinase II-Ikaros axis.
Gowda CS; Song C; Ding Y; Kapadia M; Dovat S
J Investig Med; 2016 Mar; 64(3):735-9. PubMed ID: 26912004
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the short isoform of Helios overexpressed in patients with T-cell malignancies.
Tabayashi T; Ishimaru F; Takata M; Kataoka I; Nakase K; Kozuka T; Tanimoto M
Cancer Sci; 2007 Feb; 98(2):182-8. PubMed ID: 17297655
[TBL] [Abstract][Full Text] [Related]
32. Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors.
Kelley CM; Ikeda T; Koipally J; Avitahl N; Wu L; Georgopoulos K; Morgan BA
Curr Biol; 1998 Apr; 8(9):508-15. PubMed ID: 9560339
[TBL] [Abstract][Full Text] [Related]
33. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.
Mullighan CG; Miller CB; Radtke I; Phillips LA; Dalton J; Ma J; White D; Hughes TP; Le Beau MM; Pui CH; Relling MV; Shurtleff SA; Downing JR
Nature; 2008 May; 453(7191):110-4. PubMed ID: 18408710
[TBL] [Abstract][Full Text] [Related]
34. Inherited GATA2 Deficiency Is Dominant by Haploinsufficiency and Displays Incomplete Clinical Penetrance.
Oleaga-Quintas C; de Oliveira-Júnior EB; Rosain J; Rapaport F; Deswarte C; Guérin A; Sajjath SM; Zhou YJ; Marot S; Lozano C; Branco L; Fernández-Hidalgo N; Lew DB; Brunel AS; Thomas C; Launay E; Arias AA; Cuffel A; Monjo VC; Neehus AL; Marques L; Roynard M; Moncada-Vélez M; Gerçeker B; Colobran R; Vigué MG; Lopez-Herrera G; Berron-Ruiz L; Méndez NHS; O'Farrill Romanillos P; Le Voyer T; Puel A; Bellanné-Chantelot C; Ramirez KA; Lorenzo-Diaz L; Alejo NR; de Diego RP; Condino-Neto A; Mellouli F; Rodriguez-Gallego C; Witte T; Restrepo JF; Jobim M; Boisson-Dupuis S; Jeziorski E; Fieschi C; Vogt G; Donadieu J; Pasquet M; Vasconcelos J; Ardeniz FO; Martínez-Gallo M; Campos RA; Jobim LF; Martínez-Barricarte R; Liu K; Cobat A; Abel L; Casanova JL; Bustamante J
J Clin Immunol; 2021 Apr; 41(3):639-657. PubMed ID: 33417088
[TBL] [Abstract][Full Text] [Related]
35. Transcription factor Ikaros represses protein phosphatase 2A (PP2A) expression through an intronic binding site.
Nagpal K; Watanabe KS; Tsao BP; Tsokos GC
J Biol Chem; 2014 May; 289(20):13751-7. PubMed ID: 24692537
[TBL] [Abstract][Full Text] [Related]
36. A variant in human AIOLOS impairs adaptive immunity by interfering with IKAROS.
Yamashita M; Kuehn HS; Okuyama K; Okada S; Inoue Y; Mitsuiki N; Imai K; Takagi M; Kanegane H; Takeuchi M; Shimojo N; Tsumura M; Padhi AK; Zhang KYJ; Boisson B; Casanova JL; Ohara O; Rosenzweig SD; Taniuchi I; Morio T
Nat Immunol; 2021 Jul; 22(7):893-903. PubMed ID: 34155405
[TBL] [Abstract][Full Text] [Related]
37. Ikaros and tumor suppression in acute lymphoblastic leukemia.
Payne KJ; Dovat S
Crit Rev Oncog; 2011; 16(1-2):3-12. PubMed ID: 22150303
[TBL] [Abstract][Full Text] [Related]
38. Ikaros-family proteins: in search of molecular functions during lymphocyte development.
Cobb BS; Smale ST
Curr Top Microbiol Immunol; 2005; 290():29-47. PubMed ID: 16480038
[TBL] [Abstract][Full Text] [Related]
39. Ikaros interactions with CtBP reveal a repression mechanism that is independent of histone deacetylase activity.
Koipally J; Georgopoulos K
J Biol Chem; 2000 Jun; 275(26):19594-602. PubMed ID: 10766745
[TBL] [Abstract][Full Text] [Related]
40. Biclonal and biallelic deletions occur in 20% of B-ALL cases with IKZF1 mutations.
Dupuis A; Gaub MP; Legrain M; Drenou B; Mauvieux L; Lutz P; Herbrecht R; Chan S; Kastner P
Leukemia; 2013 Feb; 27(2):503-7. PubMed ID: 22868967
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
